These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33194276)

  • 1. Histopathological variation in the demyelinating sentinel lesion of primary central nervous system lymphoma.
    Bajagain M; Oyoshi T; Hanada T; Higa N; Hiraki T; Kamimura K; Kuroki S; Yoshimoto K
    Surg Neurol Int; 2020; 11():342. PubMed ID: 33194276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Demyelinating Lesions: True Sentinel Lesion or Immune-Mediated Response to Lymphoma?
    Qiu T; Chanchotisatien A; Qin Z; Wu J; Chu S
    World Neurosurg; 2021 Jan; 145():172-177. PubMed ID: 32949800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.
    XiaoHong Z; Shuo Y; GeHong D; AnChao Y; Ce W; YunYun D; Can W; SiJie H; Feng C; WenBin L
    Neurol Sci; 2023 May; 44(5):1555-1561. PubMed ID: 36599976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system lymphoma with preceding spontaneous pseudotumoral demyelination in an immunocompetent adult patient: A case report and literature review.
    Yamamoto J; Shimajiri S; Nakano Y; Nishizawa S
    Oncol Lett; 2014 Jun; 7(6):1835-1838. PubMed ID: 24932243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demyelination preceding a diagnosis of central nervous system lymphoma.
    Kalus S; Di Muzio B; Gaillard F
    J Clin Neurosci; 2016 Feb; 24():146-8. PubMed ID: 26455545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation preceding primary central nervous system lymphoma (PCNSL) - Case reports and literature review.
    Norrington M; Rathi N; Jenkinson MD; Mills SJ
    J Clin Neurosci; 2021 Jul; 89():381-388. PubMed ID: 34083111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
    Kvarta MD; Sharma D; Castellani RJ; Morales RE; Reich SG; Kimball AS; Shin RK
    BMC Neurol; 2016 May; 16():72. PubMed ID: 27206499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory Brain Lesions as Omen of Primary Central Nervous System Lymphoma: A Case Report and Literature Review.
    Kim YJ; Kim SK; Jung TY; Kim IY; Lee KH; Moon KS
    Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33557224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Central Nervous System Lymphoma with Associated Demyelination and Creutzfeldt Astrocytes.
    Achi HE; Lally JE; Riascos RF; Zhu JJ; Tandon N; Esquenazi Y; Bhattacharjee MB; Ballester LY
    Ann Clin Lab Sci; 2018 Jul; 48(4):534-537. PubMed ID: 30143499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma.
    Ng S; Butzkueven H; Kalnins R; Rowe C
    J Clin Neurosci; 2007 Nov; 14(11):1126-9. PubMed ID: 17890092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy.
    Ohe Y; Hayashi T; Mishima K; Nishikawa R; Sasaki A; Matsuda H; Uchino A; Tanahashi N
    Intern Med; 2013; 52(4):483-8. PubMed ID: 23411706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroinflammation Preceding and Accompanying Primary Central Nervous System Lymphoma: Case Study and Literature Review.
    Lu JQ; O'Kelly C; Girgis S; Emery D; Power C; Blevins G
    World Neurosurg; 2016 Apr; 88():692.e1-692.e8. PubMed ID: 26724610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory demyelinating brain lesions heralding primary CNS lymphoma.
    Husseini L; Saleh A; Reifenberger G; Hartung HP; Kieseier BC
    Can J Neurol Sci; 2012 Jan; 39(1):6-10. PubMed ID: 22384490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma.
    Sun C; Han J; Lin Y; Qi X; Li C; Liu J; Qiu F
    Front Immunol; 2022; 13():986473. PubMed ID: 36059526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of 55-year-old female with primary central nervous system lymphoma, presenting with brain and eye lesions and long-term relapsing/remitting course].
    Sasaki T; Nakayama T; Kitamura M; Kakuta Y; Imafuku I
    Rinsho Shinkeigaku; 2015; 55(8):567-72. PubMed ID: 26156255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma.
    Javier R; Shaikh N; Lesniak MS; Sonabend A; Stupp R; Behdad A; Horbinski C
    Diagn Pathol; 2018 Jun; 13(1):37. PubMed ID: 29871654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lesions of primary CNS lymphoma.
    Alderson L; Fetell MR; Sisti M; Hochberg F; Cohen M; Louis DN
    J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):102-5. PubMed ID: 8558135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.
    Kobayashi M; Shimizu Y; Shibata N; Uchiyama S
    J Neurol; 2014 Oct; 261(10):1902-10. PubMed ID: 25034274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary central nervous system cytotoxic T-cell lymphoma mimicking demyelinating disease.
    Kato Y; Hayashi T; Kawai-Masaoka A; Ichimura T; Sasaki A; Uchino A; Nagamine Y; Tanahashi N
    Intern Med; 2014; 53(11):1197-200. PubMed ID: 24881748
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.